NCT05382650View on ClinicalTrials.gov

Survey of Human Rabies Immune Globulin Safety in Children

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

February 22, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
RabiesRabies HumanRabies Virus InfectionPediatrics
Interventions
BIOLOGICAL

Human rabies immune globulin 300 IU/mL

All participants in this single-cohort observational study will receive human rabies immune globulin 300 IU/mL at a dose of 20 IU/kg per standard of care.

Trial Locations (2)

77030

RECRUITING

Houston Methodist, Houston

RECRUITING

Texas Children's Hospital, Houston

All Listed Sponsors
collaborator

Grifols Biologicals, LLC

INDUSTRY

lead

The Methodist Hospital Research Institute

OTHER